Literature DB >> 12900813

Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients.

Valentin Fuhrmann1, Peter Schenk, Christoph Mittermayer, Ibrahim El Menyawi, Klaus Ratheiser, Florian Thalhammer.   

Abstract

BACKGROUND: Ofloxacin is a quinolone administered to patients with severe infections. Pharmacokinetic data on ofloxacin in critically ill patients on renal replacement therapy are sparse and conflicting.
METHODS: Eight patients with anuric acute renal failure were administered 400 mg of ofloxacin intravenously. The pharmacokinetics of ofloxacin was analyzed during continuous venovenous hemofiltration (CVVH) with a high-flux polysulfone membrane. Serum and ultrafiltrate levels of ofloxacin were measured by means of high-performance liquid chromatography.
RESULTS: Mean serum ofloxacin concentration peak was 5.5 +/- 0.7 mg/L. Elimination half-life, hemofiltration clearance, and total removal were 2.8 +/- 0.5 hours, 89.9 +/- 4.5 mL/min, and 76.9% +/- 7.1%, respectively.
CONCLUSION: Ofloxacin is significantly and rapidly eliminated by CVVH with a high-flux polysulfone membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900813     DOI: 10.1016/s0272-6386(03)00656-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

Review 1.  Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

Authors:  Federico Pea; Pierluigi Viale; Federica Pavan; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial.

Authors:  Dominique Breilh; Patrick M Honore; David De Bels; Jason A Roberts; Jean Baptiste Gordien; Catherine Fleureau; Antoine Dewitte; Julien Coquin; Hadrien Rozé; Paul Perez; Rachid Attou; Sebastien Redant; Luc Kugener; Marie-Claude Saux; Herbert D Spapen; Alexandre Ouattara; Olivier Joannes-Boyau
Journal:  J Transl Int Med       Date:  2019-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.